Cancers (Feb 2023)

Prophylactic Radical Fimbriectomy with Delayed Oophorectomy in Women with a High Risk of Developing an Ovarian Carcinoma: Results of a Prospective National Pilot Study

  • Eric Leblanc,
  • Fabrice Narducci,
  • Gwenaël Ferron,
  • Audrey Mailliez,
  • Jean-Yves Charvolin,
  • El Hajj Houssein,
  • Frédéric Guyon,
  • Virginie Fourchotte,
  • Eric Lambaudie,
  • Agathe Crouzet,
  • Yves Fouche,
  • Sébastien Gouy,
  • Pierre Collinet,
  • Frédéric Caquant,
  • Christophe Pomel,
  • François Golfier,
  • Véronique Vaini-Cowen,
  • Isabelle Fournier,
  • Michel Salzet,
  • Emmanuelle Tresch,
  • Alicia Probst,
  • Anne-Sophie Lemaire,
  • Marie-Cécile Le Deley,
  • Delphine Hudry

DOI
https://doi.org/10.3390/cancers15041141
Journal volume & issue
Vol. 15, no. 4
p. 1141

Abstract

Read online

Risk-reducing salpingo-oophorectomy is the gold standard for the prophylaxis of ovarian cancer in high-risk women. Due to significant adverse effects, 20–30% of women delay or refuse early oophorectomy. This prospective pilot study (NCT01608074) aimed to assess the efficacy of radical fimbriectomy followed by a delayed oophorectomy in preventing ovarian and pelvic invasive cancer (the primary endpoint) and to evaluate the safety of both procedures. The key eligibility criteria were pre-menopausal women ≥35 years with a high risk of ovarian cancer who refused a risk-reducing salpingo-oophorectomy. All the surgical specimens were subjected to the SEE-FIM protocol. From January 2012 to October 2014, 121 patients underwent RF, with 51 in an ambulatory setting. Occult neoplasia was found in two cases, with one tubal high-grade serous ovarian carcinoma. Two patients experienced grade 1 intraoperative complications. No early or delayed grade ≥3 post-operative complications occurred. After 7.3 years of median follow-up, no cases of pelvic invasive cancer have been noted. Three of the fifty-two patients developed de novo breast cancer. One BRCA1-mutated woman delivered twins safely. Twenty-five patients underwent menopause, including fifteen who had received chemotherapy for breast cancer, and twenty-three underwent menopause before the delayed oophorectomy, while two did not undergo a delayed oophorectomy at all. Overall, 46 women underwent a delayed oophorectomy. No abnormalities were found in any delayed oophorectomy specimens. Radical fimbriectomy followed by delayed oophorectomy appears to be a safe and well-tolerated risk-reducing approach, which avoids early menopause for patients with a high risk of breast and ovarian cancer.

Keywords